Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy and Safety Study of Immunomodulator as an Adjunct Therapy in Pulmonary Tuberculosis (TB) Retreatment Patients

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
SK Sharma, All India Institute of Medical Sciences, New Delhi
ClinicalTrials.gov Identifier:
NCT00265226
First received: December 13, 2005
Last updated: January 3, 2014
Last verified: July 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2011
  Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)